课题基金 / 基金详情

Defining drug delivery into and across the oral mucosa using a tissue engineering and mathematical modelling approach

Defining drug delivery into and across the oral mucosa using a tissue engineering and mathematical modelling approach
使用组织工程和数学建模方法定义进入和穿过口腔粘膜的药物输送
批准号:
NC/W001160/1
负责人:
Craig Murdoch
金额:
$54.84万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2021
资助国家:
英国
项目状态:
未结题
起止时间:
2021 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Most drugs are delivered either in tablet form or by injection. However, these routes have a number of drawbacks such as drug degradation before reaching the bloodstream or patient discomfort and needle anxiety, which has led to the search for different modes of treatment. Drug delivery into or through the oral mucosa (the tissue that lines the inside of the mouth) using adhesive devices such as pastels, films or patches offers pain-free, self-administration of drugs and is therefore an attractive alternative. These devices could also be used to treat several oral diseases such as recurrent ulcers, painful lesions and fungal infections (thrush) that affect a surprisingly large proportion of the population. These oral diseases are often very painful, make chewing and swallowing difficult and can significantly impair quality of life.Although drug-containing devices have been developed for the skin (e.g., nicotine patch), this tissue is highly impermeable and so delivering drugs into or through it and into the bloodstream is difficult and inefficient. However, the oral mucosa is vastly more permeable than skin making it an ideal target for drug delivery either directly to the oral tissue or into the circulation, depending on the type of drug delivered. At present there are very few drugs that are delivered via the oral mucosa but advancement in the way in which oral drug delivery devices are manufactured has created new interest in this area, in particular for needle-free drug delivery. Optimising oral mucosal drug delivery is extremely important. The best and most efficient way to do this is to use mathematical and computational models. Mathematical models are exceptionally useful tools for studying biological systems and are being increasingly used in medical research. By writing down the underlying physical and biochemical processes of a biological system in the form of mathematical equations, one can quickly and efficiently simulate these biological processes on a computer. These mathematical models can then be used to test many different theories, make predictions and trial numerous experimental scenarios virtually by computer simulation. Importantly, the net effect of their use is to reduce the number of animal experiments needed in drug development research. A good mathematical model of drug delivery can forecast how to best optimise treatment by determining such factors as: how long the drug will stay in the mucosal tissue or how quickly it will enter the bloodstream, how often to take the drug, the ideal chemical properties of the drug and the differences between drug delivery to healthy and diseased human tissue. Unfortunately, at present, mathematical models representing the oral mucosa for this purpose have not yet been developed. Our aim is to readdress this by using biological data obtained from human tissue to create a virtual oral mucosal model that can then be used to predict drug delivery outcomes for a variety of different drugs. It is envisaged that this will dramatically increase the number of drugs that will be available for injection-free mucosal delivery.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
酶响应的中性粒细胞外泌体载药体系在眼眶骨缺损修复中的作用及机制研究
  • 批准号:
    82371102
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    苏蕴
  • 依托单位:
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
背根神经节中Mrgprd通过一种特异性lncRNA调控阿片类药物耐受的外周机制研究
  • 批准号:
    82371224
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    马柯
  • 依托单位:
不同功能基团的电中性Drug-Free纳米颗粒的构建及克服肿瘤耐药的研究
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    杨胜彩
  • 依托单位: